http://www.bloomberg.com/apps/news?pid=20601081&sid=aImw1nInTWfA&refer=australia
Human Trials
Thoratec is redesigning its own next-generation device, called HeartMate III, to make it smaller, said Chief Executive Officer Gary Burbach in an interview. Burbach didn't say when it might be ready for human trials. Thoratec may supplement its pipeline by licensing or purchasing a new device, and rivals won't hurt Thoratec's revenue potential, he said.
``It's not a zero sum game,'' Burbach said. ``There is a tremendous opportunity for growth for ourselves as well as for successful competitive devices.''
- Forums
- ASX - By Stock
- HTW
- reason for stock run up
HTW
heartware limited
reason for stock run up
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)